AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26638037 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted PNES diagnosis and inpatient psychiatry consult (n=10)
Number of subjects: 37
Study 26638037 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly follow‐up phone calls in addition to scripted diagnosis and inpatient psychiatry consultation (n=15)
Number of subjects: 37
Study 26638037 — intervention group
Group type: COMPARATOR
Intervention: PNES diagnosis delivered per the discretion of the attending physician with advice to seek mental health assistance in the community (n=12)
Number of subjects: 37
Study 25546486 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rate cut-off ICD programming (arm B)
Number of subjects: 1498
Study 25546486 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed VT therapy ICD programming (arm C)
Number of subjects: 1498
Study 25546486 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICD programming (arm A)
Number of subjects: 1498
Study 25546486 — intervention group
Group type: EXPERIMENTAL
Intervention: First inappropriate ICD therapy
Number of subjects: 1498
Study 25546486 — intervention group
Group type: EXPERIMENTAL
Intervention: First appropriate ICD therapy
Number of subjects: 1498
Study 23546631 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative electroacupuncture (PrEA)
Number of subjects: 178
Study 23546631 — intervention group
Group type: COMPARATOR
Intervention: Post-operative electroacupuncture (PoEA)
Number of subjects: 178
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time <3 hours
Number of subjects: 686
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time 3 to 5 hours
Number of subjects: 686
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time >=5 hours
Number of subjects: 686
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time >=5 hours (adjusted)
Number of subjects: 686
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time
Number of subjects: 686
Study 20494656 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular systolic ejection fraction <=40%
Number of subjects: 686
Study 18602312 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) used in combination with autologous bone grafting
Number of subjects: 34
Study 18602312 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone grafting alone
Number of subjects: 34
Study 17023234 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-Daily Controlled-Release Carvedilol CR
Number of subjects: 0
Study 17023234 — intervention group
Group type: COMPARATOR
Intervention: Twice-Daily Immediate-Release Carvedilol IR
Number of subjects: 0
Study 12794835 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg twice weekly)
Number of subjects: 30
Study 12794835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12794835 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (after switching from placebo)
Number of subjects: 30
Study 12794835 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 30
Study 12794835 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept cessation
Number of subjects: 30
Study 11027115 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide (Arava‐Aventis)
Number of subjects: 0
Study 11027115 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate or Sulfasalazine
Number of subjects: 0
Study 8803463 — intervention group
Group type: EXPERIMENTAL
Intervention: Uro-Vaxom
Number of subjects: 0
Study 8803463 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy and Uro-Vaxom
Number of subjects: 0
Study 1622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy + tamoxifen 30 mg daily for 48 weeks
Number of subjects: 3640
Study 1622643 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 3640
Study 1622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 3640
Study 1622643 — intervention group
Group type: COMPARATOR
Intervention: Non-treated patients
Number of subjects: 3640
Study 1622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated patients
Number of subjects: 3640
Study 1622643 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated patients
Number of subjects: 3640
Study 6381314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalexin b.i.d.
Number of subjects: 65
Study 6381314 — intervention group
Group type: COMPARATOR
Intervention: Cephalexin q.i.d.
Number of subjects: 65
Study 6381314 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (b.i.d. and q.i.d.)
Number of subjects: 65
Study 29934701 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoids mixture (diosmin, troxerutin, rutin, hesperidin, quercetin)
Number of subjects: 154
Study 29934701 — intervention group
Group type: COMPARATOR
Intervention: Control group (diosmin in combination with hesperidin, diosmetin, isoroifolin, and linarin in purified micronized fraction)
Number of subjects: 154
Study 26910697 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative arnica cream treatment (Group 1, n = 36)
Number of subjects: 108
Study 26910697 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mucopolysaccharide polysulfate cream treatment (Group 2, n = 36)
Number of subjects: 108
Study 26910697 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 3, n = 36)
Number of subjects: 108
Study 24281981 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (initial dose 10 μg, increments/decrements of 5 μg)
Number of subjects: 40
Study 24281981 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 40
Study 22469168 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-coaching program
Number of subjects: 950
Study 22469168 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 950
Study 20357486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dpg-Pol extracts (100 HEPL/ml) administered with 6 up-dosing and monthly maintenance injections for 1 year
Number of subjects: 0
Study 20357486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18478481 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (LD, 1.5 g NS day (‐1))
Number of subjects: 656
Study 18478481 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (HD, 3.0 g NS day (‐1))
Number of subjects: 656
Study 18478481 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 656
Study 15838189 — intervention group
Group type: EXPERIMENTAL
Intervention: SUMIT intervention
Number of subjects: 0
Study 15838189 — intervention group
Group type: COMPARATOR
Intervention: Comparison arm
Number of subjects: 0
Study 12496528 — intervention group
Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy
Number of subjects: 20
Study 12496528 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic esophagectomy
Number of subjects: 20
Study 12496528 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical approaches
Number of subjects: 20
Study 12496528 — intervention group
Group type: COMPARATOR
Intervention: Preoperative immune function
Number of subjects: 20
Study 12496528 — intervention group
Group type: COMPARATOR
Intervention: Duration of anesthesia
Number of subjects: 20
Study 12496528 — intervention group
Group type: COMPARATOR
Intervention: Preoperative interferon-gamma production
Number of subjects: 20
Study 10910855 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine plus clonidine (LC)
Number of subjects: 86
Study 10910855 — intervention group
Group type: COMPARATOR
Intervention: Clonidine (C)
Number of subjects: 86
Study 10910855 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine (L)
Number of subjects: 86
Study 10910855 — intervention group
Group type: COMPARATOR
Intervention: Clonidine groups (C and LC)
Number of subjects: 86
Study 10910855 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 86
Study 8660169 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral treatment (specific agents not detailed)
Number of subjects: 76
Study 1381018 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg daily)
Number of subjects: 53
Study 1381018 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (40 mg daily)
Number of subjects: 53
Study 6347498 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee after placebo
Number of subjects: 12
Study 6347498 — intervention group
Group type: COMPARATOR
Intervention: Coffee after propranolol (nonselective beta-blockade)
Number of subjects: 12
Study 6347498 — intervention group
Group type: COMPARATOR
Intervention: Coffee after metoprolol (beta 1-selective blockade)
Number of subjects: 12
Study 29428830 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise and home-based exercise (combined)
Number of subjects: 213
Study 29428830 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study 29428830 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 213
Study 29428830 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 213
Study 27419856 — intervention group
Group type: EXPERIMENTAL
Intervention: Group medical visits (GMVs) incorporating CAM therapies (mindfulness techniques, movement, guided imagery, relaxation training, yoga, qigong, t'ai chi)
Number of subjects: 42
Study 27419856 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 42
Study 24144212 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg/day hydroxyurea (HU)
Number of subjects: 61
Study 24144212 — intervention group
Group type: COMPARATOR
Intervention: 20 mg/kg/day hydroxyurea (HU)
Number of subjects: 61
Study 22108765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 114
Study 22108765 — intervention group
Group type: COMPARATOR
Intervention: FM education
Number of subjects: 114
Study 19888959 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted surgery within an ERP
Number of subjects: 22
Study 19888959 — intervention group
Group type: COMPARATOR
Intervention: Open surgery within an ERP
Number of subjects: 22
Study 18161668 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary thromboprophylaxis (PTP) with unfractionated heparin (5‐10 units/kg/hr) infusion postoperatively, followed by subcutaneous low molecular weight heparin (LMWH) at prophylactic dose (0.5 mg/kg/d) and therapeutic dose (1 mg/kg/d) based on thrombosis predisposition.
Number of subjects: 21
Study 18161668 — intervention group
Group type: COMPARATOR
Intervention: No-treatment group (Historical group) with 12 AVFs that did not receive thromboprophylaxis.
Number of subjects: 21
Study 18161668 — intervention group
Group type: COMPARATOR
Intervention: Aspirin group (Historical group) with 5 AVFs receiving 81 mg aspirin/day.
Number of subjects: 21
Study 18161668 — intervention group
Group type: COMPARATOR
Intervention: LMWH group (Historical group) with 2 AVFs receiving LMWH.
Number of subjects: 21
Study 16309093 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-massage comprehensive program
Number of subjects: 180
Study 16309093 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 180
Study 16309093 — intervention group
Group type: COMPARATOR
Intervention: Massage
Number of subjects: 180
Study 16309093 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 180
Study 12530749 — intervention group
Group type: EXPERIMENTAL
Intervention: Aural lists
Number of subjects: 99
Study 12530749 — intervention group
Group type: COMPARATOR
Intervention: Visually presented words
Number of subjects: 99
Study 12530749 — intervention group
Group type: COMPARATOR
Intervention: Pictorial images
Number of subjects: 99
Study 10984382 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with a standardized latex extract
Number of subjects: 17
Study 10984382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 8636753 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene (60 mg orally per day for 3 years)
Number of subjects: 49
Study 8636753 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (20 mg orally per day for 3 years)
Number of subjects: 49
Study 1592840 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 1
Study 1592840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 3863624 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2 gel (0.5 mg dose)
Number of subjects: 48
Study 3863624 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 31504908 — intervention group
Group type: EXPERIMENTAL
Intervention: Climatized environment (26°C)
Number of subjects: 300
Study 31504908 — intervention group
Group type: COMPARATOR
Intervention: Non‐climatized environment (29°C)
Number of subjects: 300
Study 29701621 — intervention group
Group type: EXPERIMENTAL
Intervention: VYC-17.5L
Number of subjects: 123
Study 29701621 — intervention group
Group type: COMPARATOR
Intervention: Control HA dermal filler
Number of subjects: 123
Study 27295427 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study 27295427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 25315644 — intervention group
Group type: EXPERIMENTAL
Intervention: Your Path to Transplant (YPT) intervention
Number of subjects: 900
Study 25315644 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Control Education (UC)
Number of subjects: 900
Study 22341081 — intervention group
Group type: EXPERIMENTAL
Intervention: PathFile (P)
Number of subjects: 16
Study 22341081 — intervention group
Group type: COMPARATOR
Intervention: Stainless-steel K-file (K)
Number of subjects: 16
Study 21046498 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional thyroidectomy (Group 1)
Number of subjects: 142
Study 21046498 — intervention group
Group type: COMPARATOR
Intervention: Flapless conventional thyroidectomy (Group 2)
Number of subjects: 142
Study 17335011 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet questionnaire
Number of subjects: 1071
Study 17335011 — intervention group
Group type: COMPARATOR
Intervention: Written questionnaire
Number of subjects: 1071
Study 15910726 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatogastrostomy (PG)
Number of subjects: 149
Study 15910726 — intervention group
Group type: COMPARATOR
Intervention: Pancreatojejunostomy (PJ)
Number of subjects: 149
Study 15910726 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality rate
Number of subjects: 149
Study 15910726 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperations and/or postoperative interventional radiology drainages
Number of subjects: 149
Study 15910726 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of hospital stay
Number of subjects: 149
Study 15618687 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 200 mg alone (Study 1)
Number of subjects: 0
Study 15618687 — intervention group
Group type: COMPARATOR
Intervention: Cefdinir 200 mg and calcium polycarbophil 1200 mg (Study 2)
Number of subjects: 0
Study 10443862 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric evaluation and management (GEM) with DETERMINE Checklist scores of four or higher
Number of subjects: 251
Study 10443862 — intervention group
Group type: COMPARATOR
Intervention: Geriatric evaluation and management (GEM) with DETERMINE Checklist scores lower than four
Number of subjects: 251
Study 10443862 — intervention group
Group type: EXPERIMENTAL
Intervention: DETERMINE Checklist scores
Number of subjects: 251
Study 8847680 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 45
Study 8847680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 2259185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg orally twice a day for 14 days and an additional 400 mg intravenously during hemodialysis)
Number of subjects: 8
Study 2259185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral treatment)
Number of subjects: 8
Study 31802692 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics combined with early enteral nutrition
Number of subjects: 76
Study 31802692 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition alone
Number of subjects: 76
Study 30372127 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless Steel (SS) bone screws
Number of subjects: 386
Study 30372127 — intervention group
Group type: COMPARATOR
Intervention: Titanium Alloy (TiA) bone screws
Number of subjects: 386
Study 27933399 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-guided clinical decision support system for rehydration treatment
Number of subjects: 222
Study 27933399 — intervention group
Group type: COMPARATOR
Intervention: Usual care by attending physician
Number of subjects: 222
Study 26324406 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-PA/high-oleic-acid (HOA) diet
Number of subjects: 0
Study 26324406 — intervention group
Group type: COMPARATOR
Intervention: High-PA (HPA) diet
Number of subjects: 0
Study 23515275 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (MED)
Number of subjects: 1212
Study 23515275 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG surgery (in patients assigned to MED who underwent CABG)
Number of subjects: 1212
Study 23515275 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG surgery (per-protocol)
Number of subjects: 1212
Study 23515275 — intervention group
Group type: COMPARATOR
Intervention: CABG to MED crossover population
Number of subjects: 1212
Study 22256652 — intervention group
Group type: EXPERIMENTAL
Intervention: Infantile Tuina treatment (tonifying Pijing, clarifying Dachangjing, Tuina on Lanmen, Qi, Fu Shangqijiegu, Guiwei, Zusanli (ST 36), Banmen, Sanguan)
Number of subjects: 240
Study 22256652 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Smecta
Number of subjects: 240
Study 19791830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib combined with capecitabine
Number of subjects: 0
Study 19791830 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine alone
Number of subjects: 0
Study 16749416 — intervention group
Group type: EXPERIMENTAL
Intervention: Forskolin at 10 mg/day orally for 6 months
Number of subjects: 40
Study 16749416 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate with two inhalations every 8 hours for 6 months
Number of subjects: 40
Study 15687789 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting discharge education
Number of subjects: 35
Study 15687789 — intervention group
Group type: COMPARATOR
Intervention: Routine hospital discharge education
Number of subjects: 35
Study 11734518 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior sub-Tenon's anaesthetic
Number of subjects: 0
Study 11734518 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar anaesthetic
Number of subjects: 0
Study 11734518 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar anaesthetic
Number of subjects: 0
Study 11734518 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 9143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord injury (injured for less than 1 year)
Number of subjects: 3
Study 9143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord injury (injured for more than 1 year)
Number of subjects: 3
Study 9143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraplegic and quadriplegic patients (40-59 and 60+ years of age)
Number of subjects: 3
Study 9143084 — intervention group
Group type: COMPARATOR
Intervention: Age-matched able-bodied controls
Number of subjects: 3
Study 8187990 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (209 sessions)
Number of subjects: 116
Study 8187990 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 116
Study 3539306 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole (TS)
Number of subjects: 126
Study 3539306 — intervention group
Group type: COMPARATOR
Intervention: Control (no TS)
Number of subjects: 126
Study 31725105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) for 12 weeks
Number of subjects: 17
Study 31725105 — intervention group
Group type: COMPARATOR
Intervention: Patient-choice diet (control) for 12 weeks
Number of subjects: 17
Study 29807694 — intervention group
Group type: EXPERIMENTAL
Intervention: GA-GYN score (derived from a predictive model utilizing components of an abbreviated geriatric assessment)
Number of subjects: 189
Study 29807694 — intervention group
Group type: EXPERIMENTAL
Intervention: GA-GYN score (in subgroup analysis)
Number of subjects: 189
Study 27110224 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% CHO ingestion (CHOI)
Number of subjects: 9
Study 27110224 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% CHO mouth rinse (CHOR)
Number of subjects: 9
Study 27110224 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 9
Study 27110224 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 9
Study 26529070 — intervention group
Group type: EXPERIMENTAL
Intervention: Flublok
Number of subjects: 2640
Study 26529070 — intervention group
Group type: COMPARATOR
Intervention: AFLURIA
Number of subjects: 2640
Study 22538270 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg b.i.d)
Number of subjects: 26
Study 22538270 — intervention group
Group type: COMPARATOR
Intervention: Brivaracetam (150 mg) alone
Number of subjects: 26
Study 19969437 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide formulation 1
Number of subjects: 32
Study 19969437 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide formulation 2
Number of subjects: 32
Study 18768019 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensodyne Sensitive (SENS)
Number of subjects: 76
Study 18768019 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-B Sensitive Advantage (OBSA)
Number of subjects: 76
Study 18768019 — intervention group
Group type: COMPARATOR
Intervention: All three brushes (SENS, OBSA, ADA)
Number of subjects: 76
Study 16902978 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal correlation (TC) mapping method during dynamic contrast-enhanced (DCE) MRI
Number of subjects: 30